Skip to content

Clinical trials

Tuberculosis, Pulmonary trials in Uganda

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Tuberculosis, Pulmonary Country / region: Uganda Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20081
20111
20161
20171
20183
20192
20201
20212
20222
20233
20242
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting6
Active, not recruiting2
Unknown status2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Centers for Disease Control and Prevention3
Global Alliance for TB Drug Development2
Johns Hopkins University2
National Institute of Allergy and Infectious Diseases (NIAID)2
National University Hospital, Singapore2
University College, London2
University of California, San Francisco2
Diascopic, LLC1
Gates Medical Research Institute1
Johns Hopkins Bloomberg School of Public Health1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Tuberculosis, Pulmonary24
Tuberculosis12
Tuberculosis, Multidrug-Resistant2
Disease1
HIV Infections1
Infections1
Latent Tuberculosis1
Lung Diseases1
Mycobacterium Infections1
Respiratory Tract Diseases1

Trials

Showing 26 to 24 of 24. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.